Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain

Molecular Carcinogenesis

Volumn 25, Issue 1, 1999, Pages 21-29

  De Miglio, Maria R ^a   Simile, Maria M ^a   Muroni, Maria R ^a   Pusceddu, Stefano ^a   Calvisi, Diego ^a   Carru, Angelo ^a   Seddaiu, Maria A ^a   Daino, Lucia ^a   Deiana, Luca ^a   Pascale, Rosa M ^a   Feo, Francesco ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Hepatocellular carcinoma; Phenotypic reversion; Preneoplastic cell growth; Resistance to hepatocarcinogenesis

Indexed keywords

DIETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA SYNTHESIS; GENE AMPLIFICATION; GENE OVEREXPRESSION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER NODULE; MALE; NONHUMAN; ONCOGENE C MYC; PARTIAL HEPATECTOMY; PRECANCER; PRIORITY JOURNAL; RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CHLOROFORM; DIETHYLNITROSAMINE; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENES, MYC; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PANCREATIC ELASTASE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0032937461     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199905)25:1<21::AID-MC3>3.0.CO;2-S     Document Type: Article

References (51)

1. Pitot HC, Neveu MJ, Hully JH, Sargent L, Pau D, Nicholson B. Gene activation and deactivation during multistage hepatocarcinogenesis in the rat. In: Columbano A, Feo F, Pani P, Pascale RM, editors. Chemical carcinogenesis. 2. Modulatory factors. New York: Plenum; 1991. p 49-64.
2. Pascale RM, Simile MM, Feo F. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy. Anticancer Res 1993;13:1341-1356.
3. Grisham JW. Interspecies comparison of liver carcinogenesis: Implications for cancer risk assessment. Carcinogenesis 1996;18:59-81.
4. Cote GJ, Lastra BA, Copk JR, Huang D-P, Chiu J-F. Oncogene expression in rat hepatomas and during hepatocarcinogenesis. Cancer Lett 1985;26:121-127.
5. Dragani TA, Manenti G, Della Porta G, Gattoni-Celli S, Weinstein IB. Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. Cancer Res 1986;46:1915-1919.
6. Suchy BK, Sarafoff M, Kerler R, Rabes HM. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. Cancer Res 1989;49:6781-6787.
7. Garcea R, Daino L, Pascale RM, et al. Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: Effect of variations of S-adenosylmethionine: S-adenosylhomocysteine ratio. Carcinogenesis 1989;10:1183-1192.
8. Zhang X-K, Huang D, Qiu D-K, Chiu J. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 1990;5:909-914.
9. Móróy T, Marchio E, Etiemble J, Trépo C, Tiallais P, Buendia MA. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 1986;324:276-279.
10. Marion PL, Davelaar MJV, Knight SS, et al. Hepatocellular carcinomas in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 1986;83:4545-4546.
11. Chandar PK, Lombardi B, Locker J. c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc Natl Acad Sci USA 1989;86:2703-2707.
12. Murakami H, Sanderson ND, Nagy P, Marino P, Merlino GP, Thorgeirsson SS. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: Interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 1993;53:1719-1723.
13. Solt DB, Medline A, Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977;88:595-618.
14. Pascale RM, De Miglio MR, Muroni MR, et al. c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model. Int J Cancer 1966;68:136-142.
15. Enomoto K, Farber E. Kinetics of phenotypic maturation of remodeling hyperplastic nodules during liver carcinogenesis. Cancer Res 1982;42:2330-2335.
16. Pascale RM, Simile MM, De Miglio MR, et al. The BN rat strain carries dominant hepatocarcinogen resistance loci. Carcinogenesis 1996;17:1765-1768.
17. Dragani TA, Manenti G, Della Porta G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res 1991;51:6299-6303.
18. Pascale RM, Marras V, Simile MM, et al. Chemoprevention of rat liver carcinogenenesis by S-adenosyl-L-methionine: A long-term study. Cancer Res 1992;52:4979-4986.
19. Asamoto M, Tsuda H, Kagawa M, de Camargo JLV, Ito N, Nagase S. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital of rat hepatocarcinogenesis in a medium-term assay system: Quantitation of glutathione-S-transferase P-positive foci development. Jpn J Cancer Res 1989;80:939-944.
20. Squire RA, Levitt MH. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res 1975;35:3214-3223.
21. Nishikura K, Ar-Rushdi A, Erikon J, Rovera G, Croce CM. Differential expression of the normal and the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci USA 1983;80: 4822-4826.
22. Khalili K, Weinmann R. Actin mRNAs in HeLa cells. Stabilization after adenovirus infection. J Mol Biol 1984;180:1007-1021.
23. Schreiber G, Dubeau L. c-myc protooncogene amplification detected by polymerase chain reaction in archival human ovarian carcinomas. Am J Pathol 1990;137:653-658.
24. Shindo M, Okuno T, Matsumoto M, et al. Detection of hepatitis B virus DNA in paraffin-embedded liver tissues in chronic hepatitis B or non-A non-B hepatitis using the polymerase chain reaction. Hepatology 1991;13:167-171.
25. Spritz RA, Jagadeeswaran P, Choudary PV, et al. Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. Proc Natl Acad Sci USA 1981;78:2455-2459.
26. Brass Nheckel D, Meese E. Comparative PCR: An improved method to determine gene amplification. Biotechniques 1998;24:22-26.
27. MacDonald RJ, Swift GH, Quinto C, et al. Primary structure of two distinct rat pancreatic preproelastases determined by sequence analysis of the complete cloned messenger ribonucleic acid sequences. Biochemistry 1982;21:1453-1463.
28. Pugh TD, King JH, Koen H, et al. Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transactions. Cancer Res 1983;43:1261-1268.
29. Garcea R, Daino L, Pascale R, et al. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: Role of remodeling and apoptosis. Cancer Res 1989;49:1850-1856.
30. Brown DM, Matise TC, Koike G, et al. An integrated genetic linkage map of the laboratory rat. Mamm Genome 1998;9:521-530.
31. Poirier MS, Hunt JM, True BA, Laishes BA, Young JF, Beland FA. DNA adduct formation, removal and persistence in rat liver during one month of feeding 2-acetylaminofluorene. Carcinogenesis 1984;5:1591-1596.
32. Epstein SM, Bendetti EL, Shinozuka H, Bartus B, Farber E. Altered and distorted DNA from a premalignant liver lesion induced by 2-fluorenylacetamide. Chem Biol Interact 1969; 1:113-124.
33. Sargent L, Xu Y-H, Sattle G, Meisner L, Pitot HC. Ploidy and karyo-type of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis 1989;10:387-391.
34. Garcea R, Pascale RM, Daino L, et al. Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5′-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. Carcinogenesis 1987;8:653-658.
35. Kekulé AS, Lauer U, Weiss L, Luber B, Hofscheneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993;36:742-745.
36. Caselman WFI, Meyer M, Kekulé AS, Lauer U, Hofschneider PH, Koshy R. A novel transactivator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 1990;87: 2790-2794.
37. Rao PM, Antony A, Rajalakshmi S, Sarma DSR. Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis 1989;10:933-937.
38. Zingg J-M, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18:869-882.
39. Sargent LM, Sattle GL, Roloff B, et al. Ploidy and specific karyo-typic changes during promotion with phenobarbital, 2,5,2′,5′-tetrachlorobiphenyl, and/or 3,4,3′,4′-tetrachlorobiphenyl in rat liver. Cancer Res 1992;52:955-962.
40. Sargent L, Gragan Y, Xu Y-H, Sattler G, Wiley J, Pitot HC. Karyo-typic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res 1996;56:2985-2991.
41. Kovi E, Morris HP. Chromosome banding studies of several transplantable hepatomas. Adv Enzyme Regul 1983;14:139-162.
42. Sargent LM, Dragan YP, Sattler GL, Xu YH, Wiley J, Pitot HC. Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms. Cancer Res 1997;57:3451-3456.
43. Meichle A, Philipp A, Eilers M. The functions of Myc proteins. Biochim Biophys Acta 1992;1114:129-146.
44. Tobias KE, Shor J, Kahana C. c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs. Oncogene 1995;11:1721-1727.
45. Pascale RM, Simile MM, Gaspa L, et al. Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. Carcinogenesis 1993;14:1077-1080.
46. Hibshoosh H, Johnson M, Weinstein IB. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene 1991;6: 739-743.
47. Auvinen M, Laine A, Paasinen-Sohns A, et al. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 1997;57:3016-3025.
48. Hoag AT, Cohen KJ, Barrett JF, Bergstrom DA, Dang CV. Participation of cyclin A in myc-induced apoptosis. Proc Natl Acad Sci USA 1994;91:6875-6879.
49. Jansen-Durr P, Meichle A, Steiner P, et al. Differential modulation of cyclin gene expression by myc. Proc Natl Acad Sci USA 1993;90:3685-3689.
50. kip1 binding to newly formed complexes. Oncogene 1997;14:2373-2381.
51. Santoni-Rugiu A, Jensen MR, Thorgeirsson SS. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor α. Cancer Res 1998;58:123-134.